These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4855871)

  • 21. Mechanisms of catecholamine inactivation by the endocrine pancreas.
    Feldman JM; Chapman B
    Diabetes; 1974 Sep; 23(9):754-62. PubMed ID: 4606797
    [No Abstract]   [Full Text] [Related]  

  • 22. A study of the role of catecholamines in the response to various central stimulants.
    Sayers AC; Handley SL
    Eur J Pharmacol; 1973 Jul; 23(1):47-55. PubMed ID: 4147437
    [No Abstract]   [Full Text] [Related]  

  • 23. Application of steady-state kinetics to the study of catecholamine turnover after monoamine oxidase inhibition or reserpine administration.
    Neff NH; Costa E
    J Pharmacol Exp Ther; 1968 Mar; 160(1):40-7. PubMed ID: 5639109
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparative effects of ethanol and malnutrition on the development of catecholamine neurons: changes in specific activities of enzymes.
    Detering N; Edwards E; Ozand P; Karahasan A
    J Neurochem; 1980 Feb; 34(2):297-304. PubMed ID: 6106048
    [No Abstract]   [Full Text] [Related]  

  • 25. Increased amphetamine stereotypy and longer haloperidol catalepsy in spontaneously hypertensive rats.
    Shipley JE; Rowland N; Antelman SM; Buggy J; Edwards DJ; Shapiro AP
    Life Sci; 1981 Feb; 28(7):745-53. PubMed ID: 7194957
    [No Abstract]   [Full Text] [Related]  

  • 26. Nitrocatechol Derivatives of Chalcone as Inhibitors of Monoamine Oxidase and Catechol-O-Methyltransferase.
    Engelbrecht I; Petzer JP; Petzer A
    Cent Nerv Syst Agents Med Chem; 2018; 18(2):115-127. PubMed ID: 29697034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of euphylline and halidor on several indices of catecholamine and serotonin metabolism in the brains and blood of rats].
    Saratikov AS; Fisanova LL; Marina TF
    Vopr Med Khim; 1977; 23(2):237-41. PubMed ID: 883160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Catalepsy induced by SCH 23390 in rats.
    Morelli M; Di Chiara G
    Eur J Pharmacol; 1985 Nov; 117(2):179-85. PubMed ID: 2866970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transdihydrolisuride, a partial dopamine receptor antagonist: effects on monoamine metabolism.
    Kehr W
    Eur J Pharmacol; 1984 Jan; 97(1-2):111-9. PubMed ID: 6421606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Depletion of catecholamines in the brain of rats differentially affects stimulation of locomotor activity by caffeine, D-amphetamine, and methylphenidate.
    Finn IB; Iuvone PM; Holtzman SG
    Neuropharmacology; 1990 Jul; 29(7):625-31. PubMed ID: 1974712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significance of dopamine receptor activity in dl-p-methoxyamphetamine- and d-amphetamine-induced locomotor activity.
    Tseng LF; Loh HH
    J Pharmacol Exp Ther; 1974 Jun; 189(3):717-24. PubMed ID: 4858403
    [No Abstract]   [Full Text] [Related]  

  • 32. Mechanism of myocardial catecholamine depletion in cardiac hypertrophy and failure in rabbits.
    Sassa H
    Jpn Circ J; 1971 Apr; 35(4):391-403. PubMed ID: 4253601
    [No Abstract]   [Full Text] [Related]  

  • 33. Unilateral catecholamine depletion of the corpus striatum and amphetamine-induced turning: an ontogenetic study.
    White BC; Tapp WN
    Psychopharmacology (Berl); 1977 Jul; 53(2):211-2. PubMed ID: 408848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of catecholamine turnover by variations of enzyme levels.
    Pletscher A
    Pharmacol Rev; 1972 Jun; 24(2):225-32. PubMed ID: 4404611
    [No Abstract]   [Full Text] [Related]  

  • 35. Catecholamine-metabolizing enzyme activity in the nigrostriatal system.
    Francis A; Whittemore R; Jeffery DR; Pearce LB; Roth JA
    Biochem Pharmacol; 1987 Jul; 36(13):2229-31. PubMed ID: 3111478
    [No Abstract]   [Full Text] [Related]  

  • 36. No change of brain extracellular catecholamine levels after acute catechol-O-methyltransferase inhibition: a microdialysis study in anaesthetized rats.
    Li YH; Wirth T; Huotari M; Laitinen K; MacDonald E; Männistö PT
    Eur J Pharmacol; 1998 Sep; 356(2-3):127-37. PubMed ID: 9774242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of depletion of cerebral monoamines on the concentration of glycogen and on amphetamine-induced glycogenolysis in the brain.
    Hutchins DA; Rogers KJ
    Br J Pharmacol; 1973 May; 48(1):19-29. PubMed ID: 4269287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolism of catecholamines by catechol-O-methyltransferase in cells expressing recombinant catecholamine transporters.
    Eshleman AJ; Stewart E; Evenson AK; Mason JN; Blakely RD; Janowsky A; Neve KA
    J Neurochem; 1997 Oct; 69(4):1459-66. PubMed ID: 9326274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Catecholamines and their metabolic enzymes in the rat myocardium after a flight on the Kosmos-936 biosatellite].
    Kwetncanski R; Tigranian RA; Torda T
    Kosm Biol Aviakosm Med; 1982; 16(3):66-8. PubMed ID: 7098414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of alpha-methyl tyrosine and adrenergic blocking agents on the facilitating action of amphetamine and nicotine on learning in rats.
    Orsingher OA; Fulginiti S
    Psychopharmacologia; 1971; 19(3):231-40. PubMed ID: 5565240
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.